Scientific development of new pain therapeutics has largely been put on hold while the industry tries to grapple with reimbursement and market access challenges first. Now in its 5th year, the
Human Abuse Liability Testing & Market Access Summit is the industry's first and largest conference devoted specifically to the latest technical and marketplace developments impacting opioids and other drugs with abuse potential. No other event gives you such intensive strategies on shrinking the abuse risk and growing the market potential for pain therapeutics.
Top Five Reasons to Attend
- Special focus on the public health indicators most crucial to securing reimbursement
- Detailed strategies for adapting to new opioid regulations, lawsuits, and insurer decisions
- Analysis of the market potential for abuse-deterrent opioids, stimulants, benzos, and cannabinoids
- Innovative study methods for new opioids with very low market share
- Tools to meet the challenges of HCP-administered opioids
Who Should Attend
This event is designed for pharma, biotech, and medical device professionals responsible for:
- Regulatory Affairs / Intelligence
- Epidemiology / Pharmacoepidemiology
- Abuse / Deterrent / Deterrence / Abuse deterrent / Abuse deterrence
- Clinical Development / Operations / Affairs / Programs
- Risk Management / REMS
- Toxicology
- Drug Safety
- Pharmacology / Clinical Pharmacology / Safety Pharmacology
- CNS / Neuroscience
- Pharmacy
- Education
- Medical Affairs
- Scientific Affairs
- Formulations
- Analytical Development
- Pharmaceutical Development
- Marketing
- Managed Care
- Market Access
- Reimbursement
- Rebate
- Clinical Development
- Preclinical Development
- R&D
- Quality
- Pharmacovigilance
- Pharmacoeconomics / Health Economics / Outcomes Research / HEOR
- Commercial Affairs
- Legal Affairs / Legal Counsel
- Policy
- Cannabis / cannabinoid
- Addiction / Addiction Treatment / Addiction Medicine
- Diversion
- Abuse / Drug Abuse
- Pharmacy
- Informatics
- Pain / Pain Medicine / Pain Management
- Anesthesiology
- Palliative Care
- Behavioral Psychiatry / Behavioral Health
This event is also of interest to:
- CROs
- Toxicology Specialists
- Drug Abuse Registry / Surveillance Specialists
- REMS / Pharmacovigilance Specialists
- Formulation Service Providers
- Pharmacokinetics Service Providers
- Abuse Liability Service Providers
- Regulatory Specialists
- Intellectual Property Service Providers
- Law firms
Speakers
- Christopher Altomare, Director of Pharmaceutical Services, DRUGSCAN
- Andy Barrett, Vice President, Scientific Affairs, KEMPHARM
- Dan Cohen, Executive Vice President, Government and Public Relations, KEMPHARM
- Karen DiDonato, Executive Director, Medical Affairs, ACELRX PHARMACEUTICALS
- Eric Galia, International Project Leader, GRUNENTHAL
- Gary Jay, Professor, Neurology, UNIVERSITY OF NORTH CAROLINA - CHAPEL HILL
- Bob Jones, CEO, ACURA PHARMACEUTICALS
- Shruti Kulkarni, Director, FORCE FOUNDATION
- Ryan Lanier, Senior Consultant, Drug Development, ANALGESIC SOLUTIONS
- Richard Mannion, former Executive Director, Pharmaceutical and Analytical Development, PURDUE PHARMA
- Andrea Maresca, Policy Director, INNOVATIVE PAIN MEDICINES ALLIANCE
- Elizabeth Nugent, Director, Clinical Research and Pharmacovigilance, RADARS SYSTEM
- Steven Passik, Vice President, Scientific Affairs, Education, and Policy, COLLEGIUM PHARMACEUTICALS
- Sebastian Schwier, International Technical Project Leader, GRUNENTHAL
- Marta Sokolowska, Vice President, Medical and External Affairs, DEPOMED
- Graham Wood, Chief R&D Officer, ALTASCIENCES CLINICAL RESEARCH
Please fill in your name and email to receive the conference agenda of this event.
Conference Day One - Monday, 5 November 2018
Conference Day Two - Tuesday, 6 November 2018
Venue
Hilton Washington Dulles Airport
13869 Park Center Rd, 20171
Herndon, VA, USA
Venue
Hilton Washington Dulles Airport13869 Park Center Road
Herndon, VA 20171
To make reservations, please call 703-478-2900 and request the negotiated rate for ExL November Meetings. You may also make reservations online using the following weblink:
Click HereThe group rate is available until October 15, 2018. Please book your room early, as rooms available at this rate are limited.
